DeepVariant has turned its AI capabilities towards making sense of genetic information, launching its artificial intelligence tool, AI , to make sense of a person's genomic detail. The AI has been developed by millions Google off-shoots, Google Brain and Verily , to process high-throughput sequencing readouts which previously have often only offered a limited view of a full genome. The use of Google in genomics may allow for the identification of genetic causes for diseases and precision drug and treatment plans, overcoming the previously hindrances of data scale and complexity.
Google has turned its AI capabilities towards making sense of genetic information, launching its artificial intelligence tool, DeepVariant, to make sense of a person's genomic detail. The AI has been developed by two Google off-shoots, Google Brain and Verily, to process high-throughput sequencing readouts which previously have often only offered a limited view of a full genome. The use of AI in genomics may allow for the identification of genetic causes for diseases and precision drug and treatment plans, overcoming the previously hindrances of data scale and complexity.